Optimal designs for dose finding studies with an active control

Journal of the Royal Statistical Society. Series B: Statistical Methodology

Volumn 76, Issue 1, 2014, Pages 265-295

  Dette, Holger ^a   Kiss, Christine ^a   Benda, Norbert ^b   Bretz, Frank ^c,d  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Federal Institute for Drugs and Medical Devices   (Germany)

^c NOVARTIS PHARMA AG   (Switzerland)

^d SHANGHAI UNIVERSITY OF FINANCE AND ECONOMICS   (China)

Author keywords

Active control; Bayesian optimal designs; Dose estimation; Dose response; Minimax design

Indexed keywords

EID: 84891829612     PISSN: 13697412     EISSN: 14679868     Source Type: Journal    
DOI: 10.1111/rssb.12030     Document Type: Article

References (48)

1. Antonijevic, Z., Pinheiro, J., Fardipour, P. and Lewis, R. J. (2010) Impact of dose selection strategies used in phase II on the probability of success in phase III. Statist. Biopharm. Res., 2, 469-486.
2. Bornkamp, B., Bretz, F., Dette, H. and Pinheiro, J. (2011) Response-adaptive dose-finding under model uncertainty. Ann. Appl. Statist., 5, no. 2B, 1611-1631.
3. Bornkamp, B., Bretz, F., Dmitrienko, A., Enas, G., Gaydos, B., Hsu, C.-H., König, F., Krams, M., Liu, Q., Neuenschwander, B., Parke, T., Pinheiro, J. C., Roy, A., Sax, R. and Shen, F. (2007) Innovative approaches for designing and analyzing adaptive dose-ranging trials. J. Biopharm. Statist., 17, 965-995.
4. Bornkamp, B. and Ickstadt, K. (2009) Bayesian nonparametric estimation of continuous monotone functions with applications to dose-response analysis. Biometrics, 65, 198-205.
5. Braess, D. and Dette, H. (2007) On the number of support points of maximin and Bayesian D-optimal designs in nonlinear regression models. Ann. Statist., 35, 772-792.
6. Bretz, F., Hsu, J., Pinheiro, J. and Liu, Y. (2008) Dose finding-a challenge in statistics. Biometr. J., 50, 480-504.
7. Bretz, F., Pinheiro, J. and Branson, M. (2005) Combining multiple comparisons and modeling techniques in dose-response studies. Biometrics, 61, 738-748.
8. Chaloner, K. and Verdinelli, I. (1995) Bayesian experimental design: a review. Statist. Sci., 10, 273-304.
9. Chaudhuri, P. and Mykland, P. A. (1995) On efficient designing of nonlinear experiments. Statist. Sin., 5, 421-440.
10. Chernoff, H. (1953) Locally optimal designs for estimating parameters. Ann. Math. Statist., 24, 586-602.
11. Cook, R. D. and Wong, W. K. (1994) On the equivalence of constrained and compound optimal designs. J. Am. Statist. Ass., 89, 687-692.
12. Dette, H. (1997) Designing experiments with respect to 'standardized' optimality criteria. J. R. Statist. Soc. B, 59, 97-110.
13. Dette, H., Bretz, F., Pepelyshev, A. and Pinheiro, J. C. (2008) Optimal designs for dose finding studies. J. Am. Statist. Ass., 103, 1225-1237.
14. Dette, H., Kiss, C., Bevanda, M. and Bretz, F. (2010) Optimal designs for the EMAX, log-linear and exponential models. Biometrika, 97, 513-518.
15. Dette, H., Melas, V. B. and Pepelyshev, A. (2008) Optimal designs for free knot least squares splines. Statist. Sin., 18, 1047-1062.
16. Dette, H., Neumeyer, N. and Pilz, K. F. (2005) A note on nonparametric estimation of the effective dose in quantal bioassay. J. Am. Statist. Ass., 100, 503-510.
17. Dette, H. and O'Brien, T. (1999) Optimality criteria for regression models based on predicted variance. Biometrika, 86, 93-106.
18. Dette, H., Pepelyshev, A., Shpilev, P. and Wong, W. (2009) Optimal designs for estimating critical effective dose under model uncertainty in a dose response study. Statist. Interfc., 2, 27-36.
19. Dette, H., Pepelyshev, A., Shpilev, P. and Wong, W. (2010) Optimal designs for discriminating between dose-response models in toxicology studies. Bernoulli, 16, 1164-1176.
20. Dette, H. and Scheder, R. (2010) A finite sample comparison of nonparametric estimates of the effective dose in quantal bioassay. J. Statist. Computn Simuln, 80, 527-544.
21. Dette, H. and Studden, W. J. (1997) Canonical Moments with Applications in Statistics, Probability and Analysis. New York: Wiley.
22. Dette, H. and Titoff, S. (2009) Optimal discrimination designs. Ann. Statist., 37, 2056-2082.
23. Dragalin, V., Bornkamp, B., Bretz, F., Miller, F., Padmanabhan, S. K., Patel, N., Perevozskaya, I., Pinheiro, J. and Smith, J. R. (2010) A simulation study to compare new adaptive dose-ranging designs. Statist. Biopharm. Res., 2, 487-512.
24. Dragalin, V., Hsuan, F. and Padmanabhan, S. K. (2007) Adaptive designs for dose-finding studies based on sigmoid emax model. J. Biopharm. Statist., 17, 1051-1070.
25. Elfving, G. (1952) Optimal allocation in linear regression theory. Ann. Statist., 23, 255-262.
26. European Medicines Agency (2005) CPMP guideline on the choice of the non-inferiority margin. Technical Report emea/cpmp/ewp/2158/99. European Medicines Agency, London. (Available from http://www.ema.europa.eu/ema.)
27. European Medicines Agency (2006) CPMP guideline on clinical investigation of medicinal products for the treatment of multiple sclerosis. Technical Reportcpmp/ewp/561/98. European Medicines Agency, London. (Available from http://www.ema.europa.eu/ema.)
28. European Medicines Agency (2011) CHMP guideline on medicinal products for the treatment of insomnia. Technical Report ema/chmp/16274/2009. European Medicines Agency, London. (Available from http://www.ema.europa.eu/ema.)
29. Fang, X. and Hedayat, A. S. (2008) Locally D-optimal designs based on a class of composed models resulted from blending Emax and one-compartment models. Ann. Statist., 36, 428-444.
30. Ford, I., Torsney, B. and Wu, C. F. J. (1992) The use of a canonical form in the construction of locally optimal designs for non-linear problems. J. R. Statist. Soc. B, 54, 569-583.
31. Gilbert, P. B. (2010) Some design issues in phase 2B vs phase 3 prevention trials for testing efficacy of products or concepts. Statist. Med., 29, 1061-1071.
32. He, Z., Studden, W. J. and Sun, D. (1996) Optimal designs for rational models. Ann. Statist., 24, 2128-2142.
33. Herzberg, A. M. and Cox, D. R. (1972) Some optimal designs for interpolation and extrapolation. Biometrika, 59, 551-561.
34. Imhof, L. A. (2001) Maximin designs for exponential growth models and heteroscedastic polynomial models. Ann. Statist., 29, 561-576.
35. International Conference on Harmonisation (1994) Ich Topic E 4: Dose response information to support drug registration. Technical Report. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva. (Available from http://www.ema.europa.eu/ema.)
36. Kiefer, J. (1974) General equivalence theory for optimum designs (approximate theory). Ann. Statist., 2, 849-879.
37. Kiefer, J. and Wolfowitz, J. (1964a) Optimum extrapolation and interpolation designs I. Ann. Inst. Statist. Math., 16, 79-108.
38. Kiefer, J. and Wolfowitz, J. (1964b) Optimum extrapolation and interpolation designs II. Ann. Inst. Statist. Math., 16, 295-303.
39. Miller, F., Guilbaud, O. and Dette, H. (2007) Optimal designs for estimating the interesting part of a dose-effect curve. J. Biopharm. Statist., 17, 1097-1115.
40. Mukhopadhyay, S. (2000) Bayesian nonparametric inference on the dose level with specified response rate. Biometrics, 56, 220-226.
41. Müller, H. and Schmitt, T. (1988) Kernel and probit estimates in quantal bioassay. J. Am. Statist. Ass., 83, 750-759.
42. Pinheiro, J., Bretz, F. and Branson, M. (2006) Analysis of dose-response studies: modeling approaches. In Dose Finding in Drug Development (ed. N. Ting ), pp. 146-171. New York: Springer.
43. Pronzato, L. and Walter, E. (1985) Robust experimental design via stochastic approximation. Math. Biosci., 75, 103-120.
44. Pukelsheim, F. (2006) Optimal Design of Experiments. Philadelphia: Society for Industrial and Applied Mathematics.
45. Ruberg, S. J. (1995) Dose response studies I: some design considerations. J. Biopharm. Statist., 5, 1-14.
46. Ting, N. (2006) Dose Finding in Drug Development. New York: Springer.
47. Yang, M. (2010) On the de la Garza Phenomenon. Ann. Statist., 38, 2499-2524.
48. Yuan, Y. and Yin, G. (2011) Dose-response curve estimation: a semiparametric mixture approach. Biometrics, 67, 1543-1554.